| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Cardiovascular Research Institute (J.Z., H.W., D.R., A.Z.-G., J.O., S.E.E.), MedStar Research Institute, Washington Hospital Center, Washington, DC; Division of Cardiology (A.A.Q.), Emory University Hospital, Atlanta, Ga; Clinical Center (G.C.), National Institutes of Health, Bethesda, Md; and Cardiology Branch (J.H.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
Correspondence to Dr Jianhui Zhu, Cardiovascular Research Institute, Washington Hospital Center, 108 Irving St NW, GHRB Room 217, Washington, DC 20010. E-mail jianhui.zhu{at}medstar.net
Objective Previous studies suggest that heat shock protein (HSP) 60 has a contributory role in atherosclerosis development. We examined whether circulating HSP70 protein and anti-HSP70 antibodies are associated with coronary artery disease (CAD).
Methods and Results Blood samples from 421 patients (62% men, mean age 57 years) evaluated for CAD by coronary angiography were tested. Serum HSP70 was detectable in 67% of study subjects with levels ranging from 0.2 to 27.1 ng/mL (mean, 1.08; median, 0.5). HSP70 levels were higher in non-CAD patients than CAD patients (median, 0.72 versus 0.34; P=0.0006). Individuals with HSP70 levels above the median (0.5 ng/mL) had half the risk of CAD than individuals with levels below the median (adjusted odds ratio, 0.52; 95% confidence limit, 0.32 to 0.86). The association of high HSP70 levels with low CAD risk was independent of traditional CAD risk factors (P=0.011). Disease severity (number of diseased vessels) was also inversely associated with HSP70 protein levels (P=0.010). The adjusted odds ratio of having multivessel disease for patients with high HSP70 protein levels was 0.54 (95% confidence limit, 0.36 to 0.81). In contrast, no association between anti-HSP70 IgG seropositivity and the prevalence of CAD was found (P=0.916).
Conclusions These data provide the first evidence that high levels of human HSP70 are associated with the low CAD risk, probably through its multiple protective effects on a cells response to stress.
Key Words: coronary artery disease heat shock protein antibodies protective effect
This article has been cited by other articles:
![]() |
N. Kupper, Y. Gidron, J. Winter, and J. Denollet Association Between Type D Personality, Depression, and Oxidative Stress in Patients With Chronic Heart Failure Psychosom Med, November 1, 2009; 71(9): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsumoto, P. C. Dimayuga, C. Wang, J. Kirzner, M. Cercek, J. Yano, K.-Y. Chyu, P. K. Shah, and B. Cercek Exogenous heat shock protein-70 inhibits cigarette smoke-induced intimal thickening Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1320 - R1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Vega, M. Rodriguez-Silva, T. Frey, M. Gehrmann, J. C. Diaz, C. Steinem, G. Multhoff, N. Arispe, and A. De Maio Hsp70 Translocates into the Plasma Membrane after Stress and Is Released into the Extracellular Environment in a Membrane-Associated Form that Activates Macrophages J. Immunol., March 15, 2008; 180(6): 4299 - 4307. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kardys, N. Rifai, O. Meilhac, J.-B. Michel, J. L. Martin-Ventura, J. E. Buring, P. Libby, and P. M Ridker Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study Clin. Chem., January 1, 2008; 54(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuchs, K. Vafeiadou, W. L Hall, H. Daniel, C. M Williams, J. H Schroot, and U. Wenzel Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shamaei-Tousi, J. P. Halcox, and B. Henderson Stressing the obvious? Cell stress and cell stress proteins in cardiovascular disease Cardiovasc Res, April 1, 2007; 74(1): 19 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Park, E.-C. Park, S. W. Bae, M. Y. Park, S. W. Kim, H. S. Yoo, M. Tudev, Y. H. Ko, Y.-H. Choi, S. Kim, et al. Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome Circulation, August 29, 2006; 114(9): 886 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
A G Pockley and J Frostegard Heat shock proteins in cardiovascular disease and the prognostic value of heat shock protein related measurements Heart, September 1, 2005; 91(9): 1124 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hagg, M. E. Johansson, J. Gronros, A. S. Naylor, I. H. Jonsdottir, G. Bergstrom, P.-A. Svensson, and L.-m. Gan Gene expression profile and aortic vessel distensibility in voluntarily exercised spontaneously hypertensive rats: potential role of heat shock proteins Physiol Genomics, August 11, 2005; 22(3): 319 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ghayour-Mobarhan, S. A New, D. J Lamb, B. J Starkey, C. Livingstone, T. Wang, N. Vaidya, and G. A Ferns Dietary antioxidants and fat are associated with plasma antibody titers to heat shock proteins 60, 65, and 70 in subjects with dyslipidemia Am. J. Clinical Nutrition, May 1, 2005; 81(5): 998 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. ARISPE, M. DOH, O. SIMAKOVA, B. KURGANOV, and A. DE MAIO Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability FASEB J, November 1, 2004; 18(14): 1636 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Martin-Ventura, M. C. Duran, L. M. Blanco-Colio, O. Meilhac, A. Leclercq, J.-B. Michel, O. N. Jensen, S. Hernandez-Merida, J. Tunon, F. Vivanco, et al. Identification by a Differential Proteomic Approach of Heat Shock Protein 27 as a Potential Marker of Atherosclerosis Circulation, October 12, 2004; 110(15): 2216 - 2219. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Hooper, J. J. Hooper, A. G. Pockley, A. Georgiades, T. Thulin, U. de Faire, and J. Frostegard Is Low-Heat Shock Protein 70 a Primary or a Secondary Event in the Development of Atherosclerosis? * Response: Is Low-Heat Shock Protein 70 a Primary or a Secondary Event in the Development of Atherosclerosis? Hypertension, April 1, 2004; 43(4): e18 - e19. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |